SCHEMBL21031065

SCHEMBL21031065

COc1nc(-n2cccn2)c(Cl)cc1C(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.37
RORC P51449 4/20 0.35
USP1 O94782 2/20 0.33
NOTUM Q6P988 1/20 0.33
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 3/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MAT2A P31153 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
ADORA2B P29275 1/20 0.32
ADORA1 P30542 1/20 0.32
MET P08581 1/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31
G6PD P11413 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23032778 0.82 ADORA2A (0.39) ADORA2ARORCNOTUMKDM4EALDH1A1
SCHEMBL21030412 0.81 NOTUM (0.40) USP1NOTUM
SCHEMBL19814369 0.81 ADORA2A (0.44) ADORA2ARORCNOTUMKDM4EALDH1A1
SCHEMBL21030417 0.80 MALT1 (0.33) LMNAPDCD1LG2CD274
SCHEMBL21031068 0.78 ADORA2A (0.37) ADORA2ARORCNOTUMMAT2ANPC1
SCHEMBL21031063 0.72 LMNA (0.37) RORCMEN1LMNAGAAKMT2A
SCHEMBL23032582 0.71 HRH4 (0.32) LMNAPDCD1LG2CD274
SCHEMBL21030629 0.69 POLB (0.38) ADORA2AUSP1NOTUMKDM4EALDH1A1
SCHEMBL20319681 0.68 MALT1 (0.41) ADORA2ANOTUMKDM4EALDH1A1MAPT
SCHEMBL14199941 0.67 NOTUM (0.53) USP1NOTUMKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190275012-A9 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS LUPIN LIMITED (IN) 2019-09-12 US disclosed
US-20190160045-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS LUPIN LTD (IN) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190275012-A9 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS MALT1, PTP4A1, PTPRO ADORA2A 4621/4885RORC 191/4885USP1 1276/4885
US-20190160045-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS MALT1, PTP4A1, PTPRO ADORA2A 4621/4885RORC 191/4885USP1 1276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.